Gene expression of nitric oxide synthase and heme oxygenase in placental villi during pregnancy with and without intrauterine growth restriction

Journal of Clinical Biochemistry and Nutrition

Volumn 32, Issue , 2002, Pages 11-21

  Muta, Kunio ^a   Masuzaki, Hideaki ^a   Urata, Yoshishige ^a   Goto, Shinji ^a   Ishimaru, Tadayuki ^a   Kondo, Takahito ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Carbon monoxide; Heme oxygenase; Intrauterine growth restriction; Nitric oxide; Nitric oxide synthase

Indexed keywords

HEME OXYGENASE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN;

ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; FEMALE; FETOPLACENTAL UNIT; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; NEWBORN; NORMAL HUMAN; NORTHERN BLOTTING; PLACENTA CIRCULATION; PLACENTA VILLUS; PREGNANCY; PROTEIN EXPRESSION; REPRODUCTION;

EID: 0038269845     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.32.11     Document Type: Article

References (37)

1. Palmer, R.M.J., Ferrige, A.G., and Moncada, S. (1987): Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327, 524-526.
2. Helmbrecht, G.D., Farhat, M.Y., Lochbaum, L., Brown, H.E., Yadgarova, K.T., Eglinton, G.S., and Ramwell, P.W. (1996) L-Arginine reverses the adverse pregnancy changes induced by nitric oxide synthase inhibition in the rat. Am. J. Obstet. Gynecol., 175, 800-805.
3. Neri, I., Mazza, V., Galassi, M.C., Volpe, A., and Facchinetti, F. (1996): Effects of L-arginine on utero-placental circulation in growth-retarded fetuses. Acta Obstet. Gynecol. Scand., 75, 208-212.
4. Vosatka, R.J., Hassoun, P.M., and Harvey-Wilkes, K.B. (1998): Dietary L-arginine prevents fetal growth restriction in rats. Am. J. Obstet. Gynecol., 178, 242-246.
5. Cacciatore, B., Halmesmäki, E., Kaaja, R., Teramo, K., and Ylikorkala, O. (1998): Effects of transdermal nitroglycerin on impedance to flow in the uterine, umbilical, and fetal middle cerebral arteries in pregnancies complicated by preeclampsia and intrauterine growth retardation. Am. J. Obstet. Gynecol. 179, 140-145.
6. Morris, N.H., Sooranna, S.R., Learmont, J.G., Poston, L., Ramsey, B., Pearson, J.D., and Steer, P.J. (1995): Nitric oxide synthase activities in placental tissue from normotensive, pre-eclamptic and growth retarded pregnancies. Br. J. Obstet. Gynaecol., 102, 711-714.
7. Lyall, F., Greer, I.A., Young, A., and Myatt, L. (1996): Nitric oxide concentrations are increased in the feto-placental circulation in intrauterine growth restriction. Placenta, 17, 165-168.
8. Yallampalli, C., Garfield, R.E., and Byam-Smith, M. (1993): Nitric oxide inhibits uterine contractility during pregnancy but not during delivery. Endocrinology, 133, 1899-1902.
9. Johnson, R.A., Lavesa, M., DeSeyn, K., Scholer, M.J., and Nasjletti, A. (1996): Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. Am. J. Physiol. 271, H1132-1138.
10. Seki, T., Naruse, M., Naruse, K., Yoshimoto, T., Tanabe, A., Tsuchiya, K., Hirose, S., Imaki, T., Nihei, H., and Demura, H. (1997): Roles of heme oxygenase/carbon monoxide system in genetically hypertensive rats. Biochem. Biophys. Res. Commun. 241, 574-578.
11. Acevedo, C.H., and Ahmed, A. (1998): Hemeoxygenase-1 inhibits human myometrial contractility via carbon monoxide and is upregulated by progesterone during pregnancy. J. Clin. Invest., 101, 949-955.
12. Barber, A., Robson, S.C., and Lyall, F. (1999): Hemoxygenase and nitric oxide synthase do not maintain human uterine quiescence during pregnancy. Am. J. Pathol. 155, 831-840.
13. Longo, M., Jain, V., Vedernikov, Y.P., Saade, G.R., Goodrum, L., Facchinetti, F., and Garfield, R.E. (1999): Effect of nitric oxide and carbon monoxide on uterine contractility during human and rat pregnancy. Am. J. Obstet. Gynecol., 181, 981-988.
14. Shibahara, S., Yoshizawa, M., Suzuki, H. Takeda, K., Meguro, K., and Endo, K. (1993): Functional analysis of cDNAs for two types of human heme oxygenase and evidence for their separate regulation. J. Biochem. (Tokyo), 113, 214-218.
15. McCoubrey, W.K., Jr., Huang, T.J., and Maines, M.D. (1997): Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur. J. Biochem., 247, 725-732.
16. Yoshiki, N., Kubota, T., and Aso, T. (2000): Expression and localization of heme oxygenase in human placental villi. Biochem. Biophys. Res. Commun., 276, 1136-1142.
17. Todoroki, S., Goto, S., Urata, Y., Komatsu, K., Sumikawa, K., Ogura, T., Matsuda, I., and Kondo, T. (1998): High concentration of L-arginine suppresses nitric oxide synthase activity and produces reactive oxygen species in NB9 human neuroblastoma cells. Mol. Med., 4, 515-524.
18. Rawlinson, S.C.F., Zaman, G., Mosley, J.R., Pitsillides, A.A., and Lanyon, L.E. (1998): Heme oxygenase isozymes in bone: Induction of HO-1 mRNA following physiological levels of mechanical loading in vivo. Bone. 23, 433-436.
19. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989): Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, New York, pp. 7-39.
20. Lees, C., Jauniaux, E., Jurkovic, D., and Campbell, S. (1998): Placental nitric oxide production and umbilical artery vascular impedance in early pregnancy. Obstet. Gynecol., 91, 761-765.
21. Ziche, M., Morbidelli, L., Masini, E., Amerini, S., Granger, H.J., Maggi, C.A., Gappetti, P., and Ledda, F. (1994): Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest., 94, 2036-2044.
22. Elbirt, K.K., and Bonkovsky, H.L. (1999): Heme oxygenase: Recent advances in understanding its regulation and role. Proc. Assoc. Am. Physicians, 111, 438-447.
23. Keyse, S.M., and Tyrrell, R.M. (1989): Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc. Natl. Acad. Sci. U.S.A., 86, 99-103.
24. Marsen,T.A., Egink, G., Suckau, G., and Baldamus, C.A. (1999): Tyrosine-kinase-dependent regulation of the nitric oxide synthase gene by endothelin-1 in human endothelial cells. Pflügers. Arch., 438, 538-544.
25. He, H., Venema, V.J., Gu, X., Venema, R.C., Marrero, M.B., and Caldwell, R.B. (1999): Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through Flk-1/KDR activation of c-Src. J. Biol. Chem., 274, 25130-25135.
26. Hoffman, A., Gloe, T., and Pohl, U. (2001): Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: A comparison between hypoxia and inhibitors of cell metabolism. J. Cell. Physiol., 188, 33-44.
27. 2+/calmodulin-dependent protein kinase II/Janus kinase 2-dependent pathway. Arterioscler Thromb. Vasc. Biol., 21, 1571-1576.
28. Kuboki, K., Jiang, Z.Y., Takahara, N., Ha, S.W., Igarashi, M., Yamauchi, T., Feener, E.P., Herbert, T.P., Rhodes, C.J., and King, G.L. (2000): Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: A specific vascular action of insulin. Circulation, 101, 676-681.
29. Tuttle, J.L., Nachreiner, R.D., Bhuller, A.S., Condict, K.W., Connors, B.A., Herring, B.P., Dalsing, M.C., and Unthank, J.L. (2001): Shear level influences resistance artery remodeling: Wall dimensions, cell density, and eNOS expression. Am. J. Physiol. Heart Circ. Physiol., 281, H 1380-1389.
30. Eto, M., Barandier, C., Rathgeb, L., Kozai, T., Joch, H., Yang, Z., and Luscher, T.F. (2001): Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: Role of Rho/ROCK and mitogen-activated protein kinase. Circ. Des., 89, 583-590.
31. Drummond, G.R., Cai, H., Davis, M.E., Ramasamy, S., and Harrison, D.G. (2000): Transcriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxidase. Circ. Des., 86, 347-354.
32. Bouloumie, A., Schini-Kerth, V.B., and Busse, R. (1999): Vascular endothelial growth factor upregulates nitric oxide synthase expression in endothelial cells. Cardiovasc. Res., 41, 509-510.
33. Rupnow, H.L., Phernetton, T.M., Shaw, C.E., Modrick, M.L., and Bird, I.M., and Magness, P.R. (2001): Endothelial vasodilator production by uterine and systemic arteries. VII. Estrogen and progesterone effects on eNOS. Am. J. Physiol. Heart Circ. Physiol., 280, H1699-1705.
34. Jayachandran, M., Hayashi, T., Sumi, D., Iguchi, A., and Miller, V.M. (2001): Temporal effects of 17beta-estradiol on caveolin-1 mRNA and protein in bovine aortic endothelial cells. Am. J. Physiol. Heart Circ. Physiol., 281, H1327-1333.
35. (x). Am. J. Physiol. Heart Circ. Physiol., 280, H1692-1698.
36. Sumi, D., Hayashi, T., Jayachandran, M., and Iguchi, A. (2001): Estrogen prevents destabilization of endothelial nitric oxide synthase mRNA induced by tumor necrosis factor alpha through estrogen receptor mediated system. Life Sci., 69, 1651-1660.
37. Hisamoto, K., Ohmichi, M., Kurachi, H., Hayakawa, J., Kanda, Y., Nishio, Y., Adachi, K., Tasaka, K., Miyoshi, E., Fujiwara, N., Taniguchi, N., and Murata, Y. (2001): Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J. Biol. Chem., 276, 3459-3467.